Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Baird analyst David Manthey initiated coverage on QXO, Inc. (NYSE:QXO) with an Outperform rating and announced a price target of $32. QXO shares closed at $19.95 on Wednesday. See how other analysts view this stock.
- Piper Sandler analyst Yasmeen Rahimi initiated coverage on Tvardi Therapeutics, …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Baird analyst David Manthey initiated coverage on QXO, Inc. (NYSE:QXO) with an Outperform rating and announced a price target of $32. QXO shares closed at $19.95 on Wednesday. See how other analysts view this stock.
- Piper Sandler analyst Yasmeen Rahimi initiated coverage on Tvardi Therapeutics, …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Baird analyst David Manthey initiated coverage on QXO, Inc. (NYSE:QXO) with an Outperform rating and announced a price target of $32. QXO shares closed at $19.95 on Wednesday. See how other analysts view this stock.
Piper Sandler analyst Yasmeen Rahimi initiated coverage on Tvardi Therapeutics, …Full story available on Benzinga.com Read MoreAU, GENI, MOD, News, QXO, Top Initiations, TVRD, Initiation, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, AU, US0351282068, MOD, US6078281002, GENI, QXO, TVRD, News, Initiation, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets
